デフォルト表紙
市場調査レポート
商品コード
1225297

インフルエンザ診断市場:世界の産業動向、シェア、規模、成長、機会、2023~2028年の予測

Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
インフルエンザ診断市場:世界の産業動向、シェア、規模、成長、機会、2023~2028年の予測
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インフルエンザ診断の世界市場規模は、2022年に8億9340万米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に6.55%の成長率(CAGR)を示し、2028年までに14億6,170万米ドルに達すると予想しています。

インフルエンザは、主に人間の鼻、喉、肺などの呼吸器系を侵すウイルス感染症です。インフルエンザ診断には、呼吸器検体中のA型およびB型インフルエンザウイルス核タンパク抗原の存在を検出するのに役立つ多くのイムノアッセイ検査が含まれます。一般的に利用可能な診断テストには、迅速抗原検査、逆転写ポリメラーゼ連鎖反応(RT-PCR)、免疫蛍光アッセイ、血清検査、迅速分子アッセイなどがあります。ヘルスケア施設は、これらのテストの精度レベルを決定する重要な要素である感度と特異性を見ることで、その精度を評価することができます。

インフルエンザ診断の市場動向

  • 喘息、慢性閉塞性肺疾患(COPD)、気管支拡張症、嚢胞性線維症など、インフルエンザのリスクを高めるいくつかの慢性疾患の有病率の上昇は、主に世界のインフルエンザ診断市場を牽引しています。このほか、呼吸器感染症にかかりやすい老年人口の拡大も、市場の成長を促しています。さらに、高度な診断用イムノアッセイフォーマットが利用可能になりつつあることや、インフルエンザ診断における小型化機器の利用が拡大していることも、世界市場にプラスの影響を及ぼしています。さらに、CLIA免除のPOC分子インフルエンザ検査の導入や、集中型ラボから分散型ポイントオブケア検査への消費者の嗜好の変化も、市場の成長を後押ししています。さらに、使い勝手がよく、約15分で結果が得られるインフルエンザ迅速診断検査(RIDT)の人気が高まっていることも、大きな成長促進要因として作用しています。さらに、インフルエンザのサーベイランス、モニタリング、データ活用を強化するためのWHO別さまざまな取り組みも、市場の成長を促しています。これに伴い、多数の政府機関が、インフルエンザのリスクを低減するための予防措置に積極的に取り組むようになっています。例えば、米国CDCと東南アジア地域(SEAR)は、鳥インフルエンザ、季節性インフルエンザ、パンデミックインフルエンザへの対応として、非研究的な二国間インフルエンザの支援に協力してきました。今後数年間、サンプル処理のタイムラインを最小化し、エラーのない結果を促進するために、インフルエンザ診断における人工知能(AI)の統合が進み、インフルエンザ診断の世界市場を牽引すると予想されます。

主な市場セグメンテーション

  • IMARC Groupは、インフルエンザ診断の世界市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供します。当レポートでは、製品、検査タイプ、インフルエンザの種類、エンドユーザーに基づいて市場を分類しています。

製品別の内訳

  • 検査キット・試薬
  • 検査機器
  • その他

検査タイプ別内訳

  • 分子生物学的診断検査
  • ポリメラーゼ連鎖反応
  • アイソトーマル核酸増幅法
  • その他の分子生物学的検査
  • 従来型診断薬
  • インフルエンザ迅速診断試験
  • ウイルス培養検査
  • 直接蛍光抗体法
  • 血清学的検査

インフルエンザの種類別内訳

  • A型インフルエンザ
  • B型インフルエンザ
  • C型インフルエンザ

エンドユーザー別内訳

  • 病院
  • 診断機関
  • その他

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東・アフリカ地域

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 インフルエンザ診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品別市場内訳

  • 検査キット・試薬
    • 市場動向
    • 市場予測
  • 計測器
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 検査タイプ別市場内訳

  • 分子生物学的診断薬
    • 市場動向
    • 主要セグメント
      • ポリメラーゼ連鎖反応
      • アイソザーマル核酸増幅法
      • その他の分子生物学的検査
    • 市場予測
  • 従来の診断薬
    • 市場動向
    • 主要セグメント
      • インフルエンザ迅速診断検査薬
      • ウイルス培養検査
      • 直接蛍光抗体法
      • 血清学的検査
    • 市場予測

第8章 インフルエンザタイプ別市場内訳

  • A型インフルエンザ
    • 市場動向
    • 市場予測
  • B型インフルエンザ
    • 市場動向
    • 市場予測
  • C型インフルエンザ
    • 市場動向
    • 市場予測

第9章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 診断ラボラトリー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Coris Bioconcept
    • Danaher Corporation
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche Ltd(Roche Holding AG)
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • Qiagen N.V
    • Quidel Corporation
    • Sekisui Diagnostics LLC(Sekisui Medical Co. Ltd.)
    • Siemens Healthineers AG(Siemens AG)
図表

List of Figures

  • Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
  • Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
  • Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
  • Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
  • Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Influenza Diagnostics Market: Competitive Structure
  • Table 8: Global: Influenza Diagnostics Market: Key Players
目次
Product Code: SR1423A138_Report

The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.

Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.

Influenza Diagnostics Market Trends:

  • The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others

Breakup by Test Type:

  • Molecular Diagnostic Tests
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Tests
  • Traditional Diagnostic Tests
  • Rapid Influenza Diagnostic Tests
  • Viral Culture Tests
  • Direct Fluorescent Antibody Test
  • Serological Tests

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
  • Key Questions Answered in This Report
  • 1. What was the size of the global influenza diagnostics market in 2022?
  • 2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
  • 3. What are the key factors driving the global influenza diagnostics market?
  • 4. What has been the impact of COVID-19 on the global influenza diagnostics market?
  • 5. What is the breakup of the global influenza diagnostics market based on the product?
  • 6. What is the breakup of the global influenza diagnostics market based on the test type?
  • 7. What is the breakup of the global influenza diagnostics market based on type of flu?
  • 8. What is the breakup of the global influenza diagnostics market based on the end user?
  • 9. What are the key regions in the global influenza diagnostics market?
  • 10. Who are the key players/companies in the global influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Influenza Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Polymerase Chain Reaction
      • 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.2.3 Other Molecular Tests
    • 7.1.3 Market Forecast
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Rapid Influenza Diagnostic Tests
      • 7.2.2.2 Viral Culture Tests
      • 7.2.2.3 Direct Fluorescent Antibody Test
      • 7.2.2.4 Serological Tests
    • 7.2.3 Market Forecast

8 Market Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type B Flu
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Type C Flu
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coris Bioconcept
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Siemens Healthineers AG (Siemens AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis